Related Experiment Videos
Detection, pathogenesis, and therapy of respiratory syncytial virus infections
1Department of Pediatrics, State University of New York at Buffalo.
Insights
Respiratory syncytial virus (RSV) causes severe infant respiratory illness. RSV research offers insights into immune responses and effective diagnostics and therapies applicable to other respiratory infections.
Area of Science:
- Virology
- Immunology
- Pediatrics
Background:
- Respiratory syncytial virus (RSV) is a primary cause of severe lower respiratory tract infections in infants and young children.
- The pathogenesis of RSV infection provides insights into the human immune system's role in respiratory illness development and protection.
Purpose of the Study:
- To explore the pathogenesis of RSV infection.
- To highlight the success of rapid diagnostic techniques for RSV.
- To discuss the potential of antiviral therapy for RSV and other respiratory infections.
Main Methods:
- Review of existing literature on RSV pathogenesis.
- Analysis of diagnostic methodologies for RSV.
- Evaluation of antiviral therapies, specifically ribavirin, for RSV.
Main Results:
- RSV infection pathogenesis offers clues to immune system involvement in respiratory illness.
- Rapid diagnostic techniques for RSV are highly successful and adaptable.
- Ribavirin therapy is an effective antiviral treatment for RSV infections.
Conclusions:
- RSV research provides a model for understanding and treating other viral, chlamydial, and mycoplasmal respiratory infections.
- Advances in RSV diagnostics and therapeutics can inform strategies for other respiratory pathogens.
- Further investigation into RSV pathogenesis can illuminate broader aspects of respiratory disease.
Abstract:
Respiratory syncytial virus (RSV) infection is a major cause of serious lower respiratory disease in infancy and early childhood. The unique pathogenesis of lower respiratory illness due to RSV offers some intriguing clues to the role of the human immune system in both protection against and development of respiratory illness. More than any other virus, rapid diagnostic techniques have been especially successful in identifying RSV infection. Many of these techniques could be easily adaptable to diagnosis of influenza virus infection and other agents. Finally, ribavirin therapy of RSV infection represents one of the few instances in which antiviral therapy has been shown to be effective for respiratory illnesses. Fundamental observations in these areas in the case of RSV infection open up new and exciting pathways for investigation of respiratory infection due to other viral, chlamydial, and mycoplasmal agents.